JPRN-jRCTs031180323招募中未知
Clinical trial of Rituximab for desensitization or antibody mediated rejection therapy in anti-donor HLA antibody positive patients - Rituximab trial
Saito Kazuhide0 个研究点目标入组 20 人开始时间: 2019年3月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients who have anti-donor antibody before or after kidney transplantation
排除标准
- •1.Pregnant, unwilling to practice contraception during the study, or lactating female
- •2.Decrease in cardiac function or lung function
- •3.Liver dysfunction (AST or ALT >3.0 x ULN, Total bilirubin > 2.0 mg/dl)
- •4.Decrease in bone marrow function (Neutrophil < 1500 /microL, platelet less than 100000 /microL, Hb < 8.0 g/dl)
- •5.Chronic or active infection (HIV or HCV or HTLV1 antibody positive, HBV DNA positive in blood, any infectious condition under Rituximab treatment)
- •6.Hypersensitivity against rituximab, mannitol, or boron
- •7.Any reason that are considered to be inadequate to attend this trial
研究者
相似试验
进行中（未招募）
不适用
Pilot study to evaluate the effect of Rituximab in combination with MTX in the inhibition of progression of synovitis, bone marrow edema, and erosions evaluated by magnetic resonance imaging (MRI) in the hand of patients with rheumatoid arthritis. - NDMedDRA version: 9.1Level: LLTClassification code 10039073Term: Rheumatoid arthritisRheumatoid arthritisEUCTR2007-001754-11-ITROCHE
已完成
不适用
ncontrolled trial of Rituximab treatment on refractory or steroid dependent nephrotic syndrome in adult.refractory or steroid dependent nephrotic syndromeJPRN-UMIN000014355Saitama Medical University Department of Nephrology5
招募中
不适用
A Phased Desensitization Protocol With Rituximab and Bortezomib for Highly HLA-sensitized Transplant Patients.JPRN-UMIN000011914Transplantation Surgery, Hiroshima University Hospital30
进行中（未招募）
不适用
A Randomized Controlled Trial of Rituximab Versus Steroids and Cyclophosphamide in the Treatment of Idiopathic Membranous Nephropathy (IMN)MN is an autoimmune disease, suggesting that the disease may be triggered by isotype specific autoantibodies directed against podocyte enzymes and podocyte receptors that are recognized as antigens. The key role of IgG antibodies formation in the pathogenesis of IMN suggests that B cell depletion may favourably impact the evolution of the glomerular disease and reduce proteinuria. We propose this study in order to test in a randomized controlled trial the hypMedDRA version: 14.1Level: PTClassification code 10018372Term: Glomerulonephritis membranousSystem Organ Class: 10038359 - Renal and urinary disordersEUCTR2011-006115-59-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
未知
2 期
Clinical study for effectiveness of rituximab for acquired coagulopathyacquired coagulopathyJPRN-UMIN000024612Gunma University10